Cargando…

Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α‐Synucleinopathies

BACKGROUND: Multiple system atrophy (MSA) and Parkinson's disease (PD) patients develop respiratory and cardiovascular disturbances including obstructive sleep apnea, orthostatic hypotension, and nocturnal stridor. We hypothesized that, associated with these respiratory and cardiovascular distu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heras‐Garvin, Antonio, Danninger, Christoph, Eschlböck, Sabine, Holton, Janice L., Wenning, Gregor K., Stefanova, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818169/ https://www.ncbi.nlm.nih.gov/pubmed/32881058 http://dx.doi.org/10.1002/mds.28229

Ejemplares similares

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
por: Kaindlstorfer, Christine, et al.
Publicado: (2018)

Signs of early cellular dysfunction in multiple system atrophy
por: Herrera‐Vaquero, M., et al.
Publicado: (2020)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy
por: Arnaldi, Dario, et al.
Publicado: (2021)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
por: Venezia, Serena, et al.
Publicado: (2017)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms
por: Eschlböck, Sabine, et al.
Publicado: (2017)

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies
por: Leys, Fabian, et al.
Publicado: (2021)

The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
por: Malfertheiner, Katja, et al.
Publicado: (2021)

Animal models of multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2015)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Cognition in multiple system atrophy: a single‐center cohort study
por: Eschlböck, Sabine, et al.
Publicado: (2020)

Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter?
por: Campese, Nicole, et al.
Publicado: (2021)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
por: Barba, Lorenzo, et al.
Publicado: (2022)

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Current experimental disease-modifying therapeutics for multiple system atrophy
por: Lemos, Miguel, et al.
Publicado: (2021)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Age‐Related Parkinsonian Signs in Microdeletion 22q11.2
por: Boot, Erik, et al.
Publicado: (2020)

Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies
por: Carli, Giulia, et al.
Publicado: (2023)

Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Natural Course of Myoclonus‐Dystonia in Adulthood: Stable Motor Signs But Increased Psychiatry
por: Timmers, Elze R., et al.
Publicado: (2020)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Ethylene augments root hypoxia tolerance via growth cessation and reactive oxygen species amelioration
por: Liu, Zeguang, et al.
Publicado: (2022)

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Every breath you don’t take, I’ll be helping you: Ethylene promotes hypoxia tolerance
por: Ugalde, José Manuel
Publicado: (2022)

Study of the persistence and dynamics of recombinant mCherry‐producing Yarrowia lipolytica strains in the mouse intestine using fluorescence imaging
por: Madzak, Catherine, et al.
Publicado: (2022)

Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies
por: Moors, Tim E., et al.
Publicado: (2022)

Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR‐mediated deletion of the SNCA gene
por: Chen, Yixi, et al.
Publicado: (2018)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

Transition to Subspecialty Sign-Out at an Academic Institution and Its Advantages
por: Conant, Joanna L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c6a3887rrmenel0mlfgjespm7l